CDH17 and cancer: We have demonstrated that nanobody‐engineered MG1655 exhibits great tumor‐homing ability towards CDH17‐expressing cancer models, and the biohybrid bacteria (Nb289‐MG1655‐CR) exhibit an excellent killing effect on CDH17‐positive cancer cells.